NCT06257264 2026-03-05A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage TumorsBeOne MedicinesPhase 1 Recruiting258 enrolled
NCT07109726 2026-02-27A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway AlterationsTerremoto Biosciences Inc.Phase 1/2 Recruiting205 enrolled
NCT05252416 2025-11-28(VELA) Study of BLU-222 in Advanced Solid TumorsBlueprint Medicines CorporationPhase 1 Terminated50 enrolled